versión On-line ISSN 1851-7617
Rev. argent. microbiol. v.37 n.3 Ciudad Autónoma de Buenos Aires jul./sep. 2005
Methicillin-resistant Staphylococcus aureus strains in Buenos Aires Teaching Hospitals: replacement of the multidrug resistant South American clone by another susceptible to rifampin, minocycline and trimethoprim-sulfamethoxazole
N. Gardella1, R. Picasso1, S.C. Predari2, M. Lasala3, M. Foccoli3, G. Benchetrit2, A. Famiglietti3, M. Catalano4, M. Mollerach1,*, G. Gutkind1
1 Cátedra de Microbiología, Facultad de Farmacia y Bioquímica, UBA, Junín 956 (1113) Ciudad Autónoma de Buenos Aires; 2Instituto de Investigaciones Médicas Alfredo Lanari, UBA, Combatientes de Malvinas 3150 (1427) Ciudad Autónoma de Buenos Aires; 3Hospital de Clínicas José de San Martín, UBA, Avenida Córdoba 2351 (1120); 4Departamento de Microbiología, Inmunología y Parasitología, Facultad de Medicina, UBA, Paraguay 2155 (1121) Ciudad Autónoma de Buenos Aires, Argentina.
*Correspondence. E-mail: email@example.com
The aim of this study was to characterize methicillin-resistant Staphylococcus aureus (MRSA) isolates recovered from different infectious sites of hospitalized patients at two university hospitals. Fourteen isolates were analyzed by repetitive sequence based PCR (Rep-PCR), randomly amplified polymorphic DNA assay (RAPD-PCR), and pulsed-field gel electrophoresis (PFGE). We found that a prevalent clone of MRSA, susceptible to rifampin, minocycline, and trimethoprim/sulfamethoxazole (RIFS, MINS, TMSS) was present in both hospitals in replacement of the multiresistant MRSA South American clone, previously described in these hospitals. The staphylococcal chromosomal cassette (SCCmec) type I element was detected in this new clone.
Key words: MRSA, mecA, SCCmec, epidemiology, molecular typing, PFGE
Staphylococcus aureus meticilina-resistente en hospitales universitarios de Buenos Aires: reemplazo del clon Sudamericano multi-resistente por otro sensible a rifampicina, minociclina y trimetoprima-sulfametoxazol. El objetivo de este trabajo fue la caracterización de aislamientos de Staphylococcus aureus meticilina-resistentes (SAMR), provenientes de diferentes procesos infecciosos de pacientes internados en dos hospitales universitarios. Catorce aislamientos fueron analizados mediante la PCR de secuencias repetitivas (Rep-PCR), la amplificación al azar de ADN polimórfico (RAPD-PCR) y la electroforesis de campo pulsado (PFGE). Encontramos que un clon prevalente de SAMR, sensible a rifampicina, minociclina y trimetoprima-sulfametoxazol (RIFS, MINS, TMSS) estaba presente en ambos hospitales, reemplazando al clon SAMR y multi-resistente previamente descrito en estos mismos hospitales. En este nuevo clon se detectó el cassette cromosómico estafilocócico SCCmec tipo I.
Palabras clave: SAMR, SCCmec, epidemiología, tipificación molecular, PFGE
Staphylococcus aureus is one of the most significant pathogens causing nosocomial infections. The prevalence of methicillin-resistant S. aureus (MRSA) differs among different countries and different hospitals, but once MRSA strains are introduced into a hospital they may become endemic. However, MRSA are also emerging in the community and the prevalence of these strains seems likely to increase substantially (4, 17). In 2003, according to the Antibiotic Resistance Informatic System (SIR), the overall prevalence of MRSA in Argentina was estimated as 56% (Subcomisión de Antimicrobianos, Asociación Argentina de Microbiología). Hospital-associated MRSA isolates were also typically resistant to multiple, non β-lactam antibiotics. In contrast, community-acquired MRSA strains are commonly susceptible to the majority of other non β-lactams (1, 15). The extensive geographic spread of specific clones of MRSA has previously been reported, and numerous procedures have been utilized for epidemiological identification and comparison of S. aureus isolates. The complete characterization of MRSA clones also requires the identification of the structural types of the large mec element, which carries methicillin resistance determinant mecA. Recently, Oliveira y de Lencastre developed and validated the application of a multiplex PCR strategy for a quick characterization of the mec element types based on their different structural features (16). Previous studies indicated that the multidrug resistant Brazilian clone, renamed as South American clone (only susceptible to glycopeptides), was the most disseminated in Buenos Aires (2, 6, 7). This clone contained the staphylococcal chromosomal cassette (SCCmec) type IIIA element (16).
The aim of this study was the molecular genotyping of MRSA isolates recovered from different infectious sites of hospitalized patients at two university hospitals, using both, unsophisticated techniques as RAPD-PCR and Rep-PCR, as well as pulsed-field gel electrophoresis (PFGE), the reference highly discriminatory method for typing MRSA isolates.
MATERIALS AND METHODS
Twenty seven isolates of S. aureus recovered from hospi-talized patients between April 2003 and June 2003 from two Buenos Aires teaching hospitals were included in this study. Fifteen isolates were from the Hospital de Clínicas José de San Martín (HC), a 500 bed general teaching hospital, and twelve from the Instituto de Investigaciones Médicas Alfredo Lanari (L), a 100 bed teaching hospital specialized in nephrology and renal transplantation. These are the two major hospitals of the University of Buenos Aires.
All isolates were identified by standard biochemical methods and associated with nosocomial infection according to the Center for Disease Control and Prevention definitions (11).
Six MRSA isolates (A1, A2, A3, A4, A5, and A6), previously characterized as different subclones of the South American clone were included in genotyping experiments (7).
Antibiotic susceptibility testing
Disk diffusion tests were performed as recommended by the Clinical and Laboratory Standards Institute (CLSI), ex National Committee for Clinical Laboratory Standards (NCCLS) (14). The following antibiotics were tested: oxacillin (OXA), 1 µg; ampicillin-sulbactam (AMS), 10/10 µg; erythromycin (ERY), 15 µg; gentamicin (GEN), 10 µg; minocycline (MIN), 30 µg; rifampin (RIF), 5 µg; trimethoprim-sulfamethoxazole (TMS), 1.25/23.75 µg; vancomycin (VAN), 30 µg; teicoplanin (TEI), 30 µg; ciprofloxacin (CIP), 5 µg; clindamycin (CLI), 2 µg.
Phenotypic evaluation of oxacillin resistance was performed by the oxacillin agar screen test (10, 20).
PCR for mecA detection and SCCmec assignment
Strategies for detecting mecA gene were performed as described elsewhere (13). S. aureus ATCC 25912 and S. aureus ATCC 43300 were used as control strains; multiplex PCR for the analysis of mec complex structure was performed as described by Olivieira and de Lencastre (7).
Bacteria were cultured overnight at 37 °C in 4 ml of Luria-Bertani broth, collected by centrifugation, resuspended in 0.1 ml of TES buffer (10 mM TrisClH pH 8.0, 1 mM EDTA, 50% sucrose) and treated with lysozyme (2 g/l) and lysostaphin (0.3 g/l) for 1 hour at 37 °C. Protoplasts were lysed by the addition of 40 µl lysis solution (10 mM TrisClH pH 8.0, 10% SDS) and 20 µl 0.5 M EDTA pH 8.0. After RNAse treatment (11 µg/ml), proteinase K was added (0.22 g/l) and extracts were incubated 60 minutes at 37 °C. DNA was purified by phenol-chloroform extractions, precipitated with ethanol and resuspended in 200 µl of MilliQ water.
PCR typing methods
Five different primers were included in the typing assays. Primers 1, 7, ERIC-2 (21) and P2 (9) were used in RAPD-PCR and RW3A (8, 22) in Rep-PCR typing.
Amplifications were performed in 50 µl of reaction buffer containing 200 µM each deoxynucleotide triphosphate, 2.5 mM MgCl2, 0.5 µM primer (primer 7, 1 or ERIC 2) 0.5 U Taq polymerase (Invitrogen) and 1 µl DNA template. PCR mixture for RAPD-PCR with primer P2 was modified in primer concentration and units of Taq polymerase (1 µM and 1.25 U, respectively). Mixture for Rep-PCR contained 200 µM each deoxynucleotide triphosphate, 1.5 mM MgCl2, 1.5 µM primer RW3A, 1 U Taq polymerase and 1 µl DNA template.
Amplification conditions for all reactions included a first cycle of 5 min at 94 °C, 15 min at the corresponding annealing temperature, 2 min at 72°C followed by 35 cycles of 1 min at 94 °C, 1 min at the annealing temperature, 2 min at 72 °C and a final step of 5 min at 72 °C. Taq polymerase was added after 5 minutes of the first annealing step in all cases. The annealing temperatures were 50 °C for primer RW3A, 42 °C for P2 and 25 °C for primers 7, 1 and ERIC 2.
PCR products were separated by 1.5% agarose gel electrophoresis in TAE 1X.
Pulsed-field gel electrophoresis (PFGE) genotyping
Eleven of the 14 MRSA isolates, ten from 12 identical isolates by PCR methods and one different (isolate H322) were studied by PFGE by means of the CHEF DR-III system (Bio-Rad, Hercules, CA, USA) using a standard protocol (5). Six isolates of the South American clone were also included.
The relatedness among patterns was estimated by the proportion of shared bands by applying the Jaccard coefficient. Data recording and calculations were performed with RAPDistance program, version 1.04 (3), and dendrogram were cons-tructed on the basis of the unweighted pair group method with arithmetic means (UPGMA method) included in Molecular Evolutionary Genetics Analysis software, version 1.02 (12).
RESULTS AND DISCUSSION
From 27 isolates included, 14 were MRSA. The susceptibility pattern of these isolates is presented in Table 1 and antibiotic susceptibility of methicillin-susceptible S. aureus (MSSA) in Table 2. The majority of the MRSA isolates were susceptible to vancomycin, rifampin, trimethoprim-sulphamethoxazole, teicoplanin and minocycline. Oxacillin agar screen test could detect all MRSA isolates, confirmed by PCR for the mecA gene.
By multiplex PCR was determined the structural type of the mec element; 13 of 14 MRSA contained SCCmec I and one isolate (H322) contained SCCmec IV (Figure 1). MRSA isolates of the multiresistant South American clone, previously detected as prevalent in the same hospitals, contained SCCmec IIIA as it was described previously (16).
PCR-based typing methods were performed on MRSA and MSSA isolates. A cut-off point of 85% was considered to define types which were coded with capital letters, and different profiles within each type were considered to represent subtypes (capital letters with numerical subscripts). Indistinguishable patterns were obtained for 12 of 14 MRSA isolates by every PCR-based typing method, producing identical grouping (Table 1). The six MRSA isolates of the South American clone previously detected as prevalent at these hospitals (6, 7) exhibited a different type pattern by these methods (data not shown). MSSA isolates (used as a control for their expected diversity) presented a high variety of types and subtypes (Table 2). These results show the ability of these methods to differentiate among unrelated strains.
Dendrogram of PFGE-constructed on the basis of similarity of levels are shown in Figure 2. At 70% similarity two clusters of MRSA isolates were defined. Cluster 1 included all MRSA recovered between December 2002 and July 2003 meanwhile MRSA of the South American clone were grouped in cluster 2. One MRSA isolate (H322) belonging to a different type by PCR typing was also included in cluster 1 by PFGE, but its inclusion was borderline with our empirical cut-off. This isolate was also the only carrying a different mec cassette.
Several works have compared different PCR based typing methods with PFGE, considered the gold standard for molecular typing MRSA (19, 21). The PCR methods used in the present work were able to identify a prevalent clone and to differentiate it from the other isolates. These methods proved to be suitable to be employed in clinical epidemiological settings allowing the prompt identification of sporadic, endemic and epidemic clones. Although PFGE detects minor variants among isolates showing indistinguishable patterns by PCR-based methods, the main disadvantages are high initial cost due to the equipment required and the time-consuming procedure. Molecular typing methods based on DNA amplification by PCR are faster and less expensive.
S. aureus isolates causing hospital infections within the studied period revealed the prevalence of a MRSA clone not previously described at these teaching hospitals. In a previous study, the Brazilian epidemic clone has been detected as predominant in these hospitals (6, 7), but the clone detected in this work has a different antibiotic susceptibility pattern, a different SCCmec element, and its different genotype was confirmed by PCR typing methods and PFGE. In 2002, a clone with an identical antibiotype was described in Córdoba province, in our country (18). Further studies are needed to explain the displacement of one clone by another in the hospital environment. Multiple factors as virulence, stability, capacity to survive in adverse environment conditions, and to colonize patients and hospital personnel, minor requirements of internal energy, considering that the new clone is more susceptible to certain antibiotics, and finally, the selective antibiotic pressure, probably had contribute to its emergence, spreading, and predominance.
Acknowledgements: This work was financed in part by grants from UBACYT, ANPCYT and Ministerio de Salud to G. Gutkind, who is a member of Carrera del Investigador Científico (CONICET). N. Gardella is a doctoral fellow of UBA, and recipient of a fellowship from Ministerio de Salud (Beca Carrillo-Oñativia).
1. Aires de Sousa M, de Lencastre H (2003) Evolution of sporadic isolates of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals and their similarities to isolates of community-acquired MRSA. J. Clin. Microbiol. 41: 3806-3815. [ Links ]
2. Aires de Sousa M, Miragaia M, Santos Sanches I, Avila S, Adamsson I, Casagrande ST, et al. (2001) Three-year assessment of methicillin-resistant Staphylococcus aureus clones in Latin America from 1996 to 1998. J. Clin. Microbiol. 39: 2197-2205. [ Links ]
3. Armstrong J, Gibbs A, Peakall RA, Weiller G. RAPDistance programs, version 1.04 for the analysis of patterns of RAPD fragments. Australian National University, Canberra, Australia 1994. [ Links ]
4. Chambers HF (2001) The changing epidemiology of Staphylococcus aureus? Emerg. Infect. Dis.7: 178-182. [ Links ]
5. Chung M, de Lencastre H, Matthews P, Tomasz A, Adamsson I, Aires de Sousa M, et al. (2000) Molecular typing of methicillin-resistant Staphylococcus aureus by pulsed-field gel electrophoresis: comparison of results obtained in a multilaboratory effort using identical protocols and MRSA strains. Microb. Drug Resist. 6: 189-198. [ Links ]
6. Corso A, Santos Sanches I, Aires de Sousa M, Rossi A, de Lencastre H (1998) Spread of a methicillin-resistant and multiresistant epidemic clone of Staphylococcus aureus in Argentina. Microb. Drug Resist. 4: 277-288. [ Links ]
7. Da Silva Coimbra M, Texeira LE, Ramos RLB, Predari SC, Castello L, Famiglietti A et al. (2000) Spread of the brazilian epidemic clone of a multiresistant MRSA in two cities in Argentina. J. Med. Microbiol. 49: 187-192. [ Links ]
8. Del Vecchio VG, Petroziello JM, Gress MJ, McCleskey FK, Melcher GP, Crouch HK, et al. (1995) Molecular genotyping of methicillin-resistant Staphylococcus aureus fluorophore-enhanced repetitive-sequence PCR. J. Clin. Microbiol. 33: 2141-2144. [ Links ]
9. Deplano A, Vaneechoutte M, Verschraegen G, Struelens MJ (1997) Typing of Staphylococcus aureus and Staphylococcus epidermidis strains by PCR analysis of inter-IS256 spacer length polymorphisms. J. Clin. Microbiol. 35: 2580-2587. [ Links ]
10. Famiglietti A, Quinteros M, Predari SC, Corso A, Lopardo H, Casellas JM, et al. (2003) Consenso sobre las pruebas de sensibilidad a los antimicrobianos en cocos gram-positivos. Rev. Argent. Microbiol. 35: 29-40. [ Links ]
11. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1998) CDC definitions for nosocomial infections, 1998. Am. J. Infect. Control 16: 128- 140. [ Links ]
12. Kumar S, Tamura K, Nei M (1993) MEGA: molecular evolutionary genetics analysis, version 1.02. The Pennsylvania State University, University Park, Pa, Estados Unidos de América. [ Links ]
13. Murakami K, Minamide W, Wada K, Nakamura E, Teraoka H, Watanabe S (1991) Identification of methicillin-resistant strains of Staphylococci by polymerase chain reaction. J. Clin. Microbiol. 29: 2240-2244. [ Links ]
14. National Committee for Clinical Laboratory Standards (2003) Performance standards for antimicrobial susceptibility testing: 12th informational supplement NCCLS document M100-S13. Wayne, PA. Estados Unidos de America. [ Links ]
15. Okuma K, Iwakawa K, Turnidge JD, Grubb WB, Bell JM, O´Brian FG, et al. (2002) Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J. Clin. Microbiol. 40: 4289-4294. [ Links ]
16. Oliveira DC, de Lencastre H (2002) Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin resistant Staphylococcus aureus. Antimicrob. Agent Chemother. 46: 2155-2161. [ Links ]
17. Shukla SK, Stemper ME, Ramaswamy SV, Conradt JM, Reich R, Graviss EA, et al. (2004) Molecular characteristics of nosocomial and native American community-associated methicillin-resistant Staphylococcus aureus clones from rural Wisconsin. J. Clin. Microbiol. 42: 3752-3757. [ Links ]
18. Sola C, Gribaudo G, Vindel A, Patrito L, Bocco JL, Córdoba MRSA Collaborative Study Group (2002) Identification of a novel methicillin-resistant Staphylococcus aureus epidemic clone in Córdoba, Argentina, involved in noso-comial infections. J. Clin. Microbiol. 40:1427-1435. [ Links ]
19. Stranden A, Frei R, Widmer AF (2003) Molecular typing of methicillin-resistant Staphylococcus aureus: can PCR replace pulsed-field gel electrophoresis? J. Clin. Microbiol. 41: 3181-3186. [ Links ]
20. Swenson JM, Spargo J, Tenover FC, Ferraro MJ (2001) Optimal inoculation methods and quality control for the NCCLS oxacillin agar screen test for detection of oxacillin resistance in Staphylococcus aureus. J. Clin. Microbiol. 39: 3781-3784. [ Links ]
21. van Belkum A, Kluytmans J, van Leeuwen W, Bax R, Quint W, Peters E, et al. (1995) Multicenter evaluation of arbitrarily primed PCR for typing of Staphylococcus aureus strains. J. Clin. Microbiol. 33: 1537-1547. [ Links ]
22. van der Zee A, Verbakel H, van Zon J-C, Frenay I, van Belkum A, Peeters M, et al. (1999) Molecular genotyping of Staphylococcus aureus strains: comparison of repetitive element sequence-based PCR with various typing methods and isolation of a novel epidemicity marker. J. Clin. Microbiol. 37: 342-349. [ Links ]